Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Cannabis & Psychedelics ETFs
Aggregate data of 7 funds
Performance
Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -5.77% | +3.81% | -17.78% | +39.37% | -35.26% | |
| Flows | +$2M | +$98M | +$5M | +$297M | +$882M | - |
Just published in Cannabis & Psychedelics
Is U.S. Cannabis Finally Becoming Investable?
Rescheduling alters operating economics in a historically constrained sector.
Movers in Cannabis & Psychedelics
Data period: March 4 - 11, 2026
Performance lists exclude leveraged and inverse ETFs
Recently launched ETFs
| Inception | ||
|---|---|---|
Screener search:
Cannabis & Psychedelics ETFsLatest news about Thematic Investing: Cannabis & Psychedelics
Is U.S. Cannabis Finally Becoming Investable?
Rescheduling alters operating economics in a historically constrained sector.
How Could the Federal Limitations on Intoxicating Hemp Reshape Cannabis Investments?
New federal hemp restrictions and rising rescheduling momentum are reshaping the outlook for cannabis ETFs and U.S. operators.
Is Cannabis Policy Shifting From Politics to Profits?
Federal cannabis rescheduling could reshape U.S. markets. Here’s what it means for businesses, policy, and cannabis ETFs eyeing new growth opportunities.
Can Psychedelics Heal Minds and Grow Portfolios?
Psychedelics offer hope for mental health treatment and attract investors despite biotech-like volatility and market shifts.
Why 2025 Could Be the Biggest Year Yet for Psychedelics and Investors
2025 sees a surge in psychedelic policy reforms, RFK Jr.’s nomination, and growing investor confidence in mental health treatment breakthroughs.
Why the DEA’s Cannabis Rescheduling Delays Matter—and How Advocates Are Fighting Back
Cannabis rescheduling hearings face delays and controversies, reflecting reform complexities and challenges for U.S. advocates.
The Worst Performing ETFs of 2024
Looking at which ETFs had the poorest returns last year.
From Potential to Policy: Cannabis in a New Political Climate
Shifting political tides and GOP support could drive cannabis growth, offering investment opportunities amid evolving U.S. policies.
November Election in the US: Psychedelics
Could the November election ignite a new wave of psychedelic policy in the U.S.?
November Election in the US: Cannabis
The upcoming November election in the US could be a pivotal moment for cannabis laws across several states.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.